Article Information
PubMed
Print ISSN
Online ISSN
History
- Accepted April 17, 2009
- Received February 2, 2009
- Published online June 18, 2009.
Article Versions
- Earlier version (April 23, 2009 - 08:13).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Valeria Chu,
- Heidi J. Einolf,
- Raymond Evers,
- Gondi Kumar,
- David Moore,
- Sharon Ripp,
- Jose Silva,
- Vikram Sinha,
- Michael Sinz and
- Andrej Skerjanec
- Sanofi-aventis United States, Bridgewater, New Jersey (V.C.); Novartis Pharmaceuticals Corporation, East Hanover, New Jersey (H.J.E.); Novartis Pharmaceuticals Corporation, Florham Park, New Jersey (A.S.); Merck & Co., Inc., Rahway, New Jersey (R.E.); Celgene Corporation, Summit, New Jersey (G.K.); Roche, Nutley, New Jersey (D.M.); Pfizer Global Research and Development, Groton, Connecticut (S.R.); Johnson & Johnson, Raritan, New Jersey (J.S.); Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (V.S.); and Bristol-Myers Squibb, Wallingford, Connecticut (M.S.)
- Address correspondence to:
Gondi Kumar, Celgene Corporation, 86 Morris Avenue, Summit, NJ 07901. E-mail: gkumar{at}celgene.com